|
Public expenditure on supply reduction policies |
public expenditure |
|
European Drug Report 2015: Trends and Developments |
alcohol | amphetamines | cannabis | chemistry | co-morbidity | cocaine | consumption rooms | crime | death | demand | drug-law offences | environmental indicators | epidemiology | evaluation | gender | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | methodology | new psychoactive substances (NPS) | older people | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | Reitox | research | seizures | social exclusion | social reintegration | spice | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people |
|
2009 Annual report on the state of the drugs problem in Europe |
amphetamines | cannabis | co-morbidity | cocaine | demand | drug-law offences | emcdda | epidemiology | evaluation | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends |
|
Financing drug policy in Europe in the wake of the economic recession |
public expenditure |
|
2010 Annual report on the state of the drugs problem in Europe |
amphetamines | cannabis | co-morbidity | cocaine | crime | death | demand | drug-law offences | emcdda | epidemiology | gender | hallucinogens | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends |
|
Estimating public expenditure on drug-law offenders in prison in Europe |
prison | public expenditure |
|
Drugnet Europe 85 |
drug-law offences | emcdda | new psychoactive substances (NPS) | public expenditure |
|
Cost and financing of drug treatment services in Europe |
public expenditure | substitution treatment | treatment |
|
Towards a better understanding of drug-related public expenditure in Europe |
public expenditure |
|
Hepatitis C and injecting drug use: impact, costs and policy options |
epidemiology | infectious diseases | injecting | policy | prevention | public expenditure |
Belgium
Bulgaria
